Early intervention with mesenchymal stem cells prevents nephropathy in diabetic rats by ameliorating the inflammatory microenvironment

Diabetic nephropathy (DN) is a major complication of diabetes and represents the leading cause of end-stage renal disease. Mesenchymal stem cell (MSC) treatment has been demonstrated to be effective in DN models by reducing albuminuria and attenuating glomerular injury; however, limited in-depth und...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yuanmin, Liu, Jingping, Liao, Guangneng, Zhang, Jie, Chen, Younan, Li, Lan, Li, Li, Liu, Fang, Chen, Bo, Guo, Gang, Wang, Chengshi, Yang, Lichuan, Cheng, Jingqiu, Lu, Yangrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846648/
https://www.ncbi.nlm.nih.gov/pubmed/29484379
http://dx.doi.org/10.3892/ijmm.2018.3501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846648/
https://www.ncbi.nlm.nih.gov/pubmed/29484379
http://dx.doi.org/10.3892/ijmm.2018.3501

Ejemplares similares